You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
The first to include the management
of Pelvic Venous Disorders
The diagnosis and categorization of PeVD have changed. Gone are the older terms of “Pelvic Congestion”, “May-Thurner” and “Nutcracker” syndromes. They were unhelpful in linking the pelvic symptoms with a patients pathology. The American Vein and Lymphatic Society have developed a new classification system for PeVD which has been included in the 2022 ESVS guidelines. It is called the SVP classification: Symptoms (S), Varices (V) and Pathophysiology (P). These occur in four anatomical zones of the abdomen and pelvis:
For patients with varicose veins and related symptoms of pelvic origin, this new SVP classification will be used in future research, in conjunction with Clinical Etiological Anatomical Pathophysiological (CEAP) classification.
For the first time, diagnosis and treatment have been recognized in the 2022 ESVS Guidelines. Below is a summary of section 7 -“The management of Pelvic Venous Disorders (PeVD) causing varicose veins.”
It is worth noting that these guidelines are written from the perspective of vascular surgeons and interventionalists. Their starting point is the presence of varicosities. From the point of view of a referrer (e.g. a gynaecologist), the starting point is the presence of pelvic symptoms. This is an important consideration when referring patients for treatment by vascular surgeons or interventionalists.